News

Novo Nordisk applies for FDA approval in tightening race for weight loss pill
Novo Nordisk, maker of Ozempic, applied for FDA approval for a weight loss pill, less than a week after rival Eli Lilly's clinical trial success.
FDA and Novo Nordisk alert consumers to counterfeit Ozempic
The U.S. Food and Drug Administration and the pharmaceutical company Novo Nordisk are urging consumers to be on the lookout ...
Health and Me on MSN16h
FDA And Novo Nordisk Warn Of Counterfeit Ozempic Circulating In US
T he US Food and Drug Administration (FDA) and pharmaceutical company Novo Nordisk are now in an attempt to making more ...